Ariston Pharma Nova Tech Private Limited

Ariston Pharma Nova Tech Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24232TG2012PTC083734 Incorporated 19 October 2012 ROC Hyderabad HQ Hyderabad, Telangana, India
Under Liquidation Private Limited Company pharma
Data last updated
Revenue · FY 2019
₹20.3 Cr
▼ 47.00% YoY
EBITDA · FY 2019
Locked
In full report
Net profit · FY 2019
Locked
In full report
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹66.99 Lakh
Issued & subscribed
Open charges
₹6.09 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Employees · EPFO
24
Latest available

About Ariston Pharma Nova Tech Private Limited

Data last updated: 22 July 2025

Ariston Pharma Nova Tech Private Limited is a private limited company based in Hyderabad, Telangana, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 19 October 2012, the company has been in operation for over 14 years.

Registered with ROC Hyderabad under CIN U24232TG2012PTC083734.

Capital: an authorised share capital of ₹1 Cr and a paid-up capital of ₹66.99 Lakh. It is led by directors including Vedprakash Vyas and Rajesh Chillale.

Last AGM: 30 September 2019. Financial statements filed for year ended 31 March 2019. Office: D No.5 – 5 – 35/136/B Ground Floor Prasanthi Nagar Ida Kukatpally, Hyderabad, Telangana, India – 500072.

As per the financials filed for FY 2019, the company reported a revenue of ₹20.3 Cr, a decline of 47% compared to the previous year.

The company has a workforce of approximately 24 employees as per the latest available data.

As per MCA filings, the company has open charges of ₹6.09 Cr on record.

The company is currently under liquidation - its assets are being sold to settle outstanding debts. It may lack the legal capacity to fulfil new agreements, and creditors are prioritised in the distribution of proceeds.

Company Details of Ariston Pharma Nova Tech Private Limited
CIN U24232TG2012PTC083734
Registration Number 083734
Incorporation Date 19 October 2012
ROC Hyderabad
Listing Status Unlisted
Company Status Under Liquidation
Date of Last AGM 30 September 2019
Date of Balance Sheet 31 March 2019
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    D No.5 – 5 – 35/136/B Ground Floor Prasanthi Nagar Ida Kukatpally, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Drug Formulation & Development
Company report
Ariston Pharma Nova Tech Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Ariston Pharma Nova Tech Private Limited report

Financials, compliance, directors, charges, ownership and filings for Ariston Pharma Nova Tech Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Ariston Pharma Nova Tech Private Limited

Ariston Pharma Nova Tech Private Limited has one previous CIN (Corporate Identification Number): U24232AP2012PTC083734. The current CIN is U24232TG2012PTC083734, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24232TG2012PTC083734 Current
U24232AP2012PTC083734 Previous

Business Activity of Ariston Pharma Nova Tech Private Limited

Ariston Pharma Nova Tech Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Ariston Pharma Nova Tech Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Ariston Pharma Nova Tech Private Limited

Auditor information for Ariston Pharma Nova Tech Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.

Board of Directors of Ariston Pharma Nova Tech Private Limited

Ariston Pharma Nova Tech Private Limited is currently managed by 5 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Vedprakash Vyas Director 19 Oct 2012 13 Years 9 Months As last reported
Rajesh Chillale Irp/Rp/Liquidator 24 May 2024 2 Years 2 Months As last reported
Subhash Goverdhandasji Bissa Director 25 Sep 2019 6 Years 10 Months As last reported
Shankar Sharma Director 16 Oct 2024 1 Years 9 Months As last reported
Rounak Sharma Director 16 Oct 2024 1 Years 9 Months As last reported

Financials of Ariston Pharma Nova Tech Private Limited FY 2019 filings available

Ariston Pharma Nova Tech Private Limited reported revenue of ₹20.3 Cr (down 47.00% YoY) for FY 2019.

Revenue · FY 2019
₹20.3 Cr ▼ 47.00%
Premium access

Ten-year financial statements for Ariston Pharma Nova Tech Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Ariston Pharma Nova Tech Private Limited

Premium access

Shareholding and ownership data for Ariston Pharma Nova Tech Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Ariston Pharma Nova Tech Private Limited

Open charges
₹6.09 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Syndicate Bank₹6.09 Cr
Latest charge details
DateLenderAmountStatus
28 Mar 2017 Syndicate Bank ₹9.4 Lakh Open
09 Nov 2015 Syndicate Bank ₹6 Cr Open

Total charge records: 2 View all charges

Employees and EPFO Compliance at Ariston Pharma Nova Tech Private Limited

Ariston Pharma Nova Tech Private Limited has a workforce of 24 employees as of Apr 06, 2024.

Employee count
24
Active EPFO establishments
1
Employee growth
-25%
Premium access

Employee and EPFO history for Ariston Pharma Nova Tech Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Ariston Pharma Nova Tech Private Limited

Premium access

GST registrations and filing compliance for Ariston Pharma Nova Tech Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Ariston Pharma Nova Tech Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Ariston Pharma Nova Tech Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Ariston Pharma Nova Tech Private Limited

Premium access

MSME payment history for Ariston Pharma Nova Tech Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Ariston Pharma Nova Tech Private Limited

Premium access

Corporate group structure for Ariston Pharma Nova Tech Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Ariston Pharma Nova Tech Private Limited

Premium access

MCA filings and documents for Ariston Pharma Nova Tech Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Ariston Pharma Nova Tech Private Limited

Directors
16 Oct 2024
Shankar Sharma was appointed as a Director on 16 Oct 2024 & has been associated with this company since 1 year 9 months.
Directors
16 Oct 2024
Rounak Sharma was appointed as a Director on 16 Oct 2024 & has been associated with this company since 1 year 9 months.
Directors
24 May 2024
Rajesh Chillale was appointed as a IRP/RP/Liquidator on 24 May 2024 & has been associated with this company since 2 years 2 months.
Activity
30 Sep 2019
Ariston Pharma Nova Tech Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Directors
25 Sep 2019
Subhash Goverdhandasji Bissa was appointed as a Director on 25 Sep 2019 & has been associated with this company since 6 years 10 months.
Activity
31 Mar 2019
Ariston Pharma Nova Tech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad.

Frequently Asked Questions about Ariston Pharma Nova Tech Private Limited

Ariston Pharma Nova Tech Private Limited is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.

Ariston Pharma Nova Tech Private Limited is a company under liquidation, formerly operating as a private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 19 October 2012 and is registered under CIN U24232TG2012PTC083734. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

Ariston Pharma Nova Tech Private Limited reported revenue of ₹20.3 Cr for FY 2019 (down 47.00% YoY).

The current directors of Ariston Pharma Nova Tech Private Limited are:

The CIN (Corporate Identification Number) of Ariston Pharma Nova Tech Private Limited is U24232TG2012PTC083734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ariston Pharma Nova Tech Private Limited has open charges of ₹6.09 Cr and no satisfied charges on record as per latest MCA filings.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available